Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
A. Papi (Ferrara, Italy), M. Castro (Kansas City, KS, United States), W. Busse (Madison, WI, United States), D. Langton (Frankston, VIC, Australia), S. Korn (Mainz, Germany), C. Xia (Tarrytown, NY, United States), X. Soler (Tarrytown, NY, United States), N. Pandit-Abid (Bridgewater, NJ, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), P. Rowe (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4321
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Papi (Ferrara, Italy), M. Castro (Kansas City, KS, United States), W. Busse (Madison, WI, United States), D. Langton (Frankston, VIC, Australia), S. Korn (Mainz, Germany), C. Xia (Tarrytown, NY, United States), X. Soler (Tarrytown, NY, United States), N. Pandit-Abid (Bridgewater, NJ, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), P. Rowe (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States). Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE. 4321
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|